Nov 23 (Reuters) - Biosyent Inc RX.V :
* "expect to see significant growth in 2016 international pharmaceutical sales over 2015"
* Biosyent releases results for third quarter and first nine months of 2016
* Q3 revenue rose 3 percent to C$4.767 million Source text for Eikon: ID:nCCN7SLvV4 Further company coverage: RX.V